173 related articles for article (PubMed ID: 21393960)
1. Exfoliative dermatitis with leukemia cutis in a patient with chronic myeloid leukemia: a rare association.
Raj A; Rai R; Rangarajan B
Indian J Dermatol Venereol Leprol; 2011; 77(2):208-10. PubMed ID: 21393960
[No Abstract] [Full Text] [Related]
2. Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate.
Anthony N; Shanks J; Terebelo H
Leuk Res; 2010 Sep; 34(9):1250-1. PubMed ID: 20646761
[No Abstract] [Full Text] [Related]
3. Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia.
Bhagavathi S; Borromeo V; Desai H; Crisan D
Ann Clin Lab Sci; 2008; 38(4):405-9. PubMed ID: 18988937
[TBL] [Abstract][Full Text] [Related]
4. Imatinib-induced erythrodermia in a patient with chronic myeloid leukemia.
Oztas P; Erbasi S; Lenk N; Polat M; Han O; Artuz F; Alli N
Acta Derm Venereol; 2006; 86(2):174-5. PubMed ID: 16648930
[No Abstract] [Full Text] [Related]
5. Chronic myeloid leukemia and gastrointestinal stromal tumor: simultaneous presentation.
Gollard R; Wierda W; Trent J
J Clin Oncol; 2007 Oct; 25(29):4682-3. PubMed ID: 17925564
[No Abstract] [Full Text] [Related]
6. Bringing prognostic scores for chronic myeloid leukemia patients up to date.
Breccia M; Alimena G
Expert Rev Hematol; 2011 Aug; 4(4):373-5. PubMed ID: 21801127
[No Abstract] [Full Text] [Related]
7. Meningeal tuberculoma mimicking chloroma in a patient with chronic myeloid leukemia on imatinib.
Salunke P; Gupta K; Singla N; Singh H; Singh P; Mukherjee KK
Neurol India; 2011; 59(4):628-30. PubMed ID: 21891950
[No Abstract] [Full Text] [Related]
8. Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign.
Banka N; Aljurf M; Hamadah I
Dermatology; 2003; 207(3):329-30. PubMed ID: 14571082
[No Abstract] [Full Text] [Related]
9. Prognostic variables in patients with chronic myeloid leukemia treated with imatinib.
Gambacorti-Passerini C
Haematologica; 2006 Feb; 91(2):145a. PubMed ID: 16461289
[No Abstract] [Full Text] [Related]
10. Listeria monocytogenes meningitis following imatinib mesylate-induced monocytopenia in a patient with chronic myeloid leukemia.
Ferrand H; Tamburini J; Mouly S; Bouscary D; Bergmann JF
Clin Infect Dis; 2005 Dec; 41(11):1684-5. PubMed ID: 16267747
[No Abstract] [Full Text] [Related]
11. Imatinib treatment of seropositive arthritis in a young woman with chronic myeloid leukemia.
Ames PR; Aye WW; Beatty C; O'Reilly D
J Rheumatol; 2008 Aug; 35(8):1682. PubMed ID: 18671330
[No Abstract] [Full Text] [Related]
12. Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate.
Yoon JY; Kumar R; Aloyz R; Johnston JB
Leuk Res; 2011 Sep; 35(9):e179-80. PubMed ID: 21802141
[No Abstract] [Full Text] [Related]
13. Development of multiple myeloma in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate for 65 months.
Michael M; Antoniades M; Lemesiou E; Papaminas N; Melanthiou F
Oncologist; 2009 Dec; 14(12):1198-200. PubMed ID: 19955186
[TBL] [Abstract][Full Text] [Related]
14. CML patient with rare b 2 a 3 (e 13 a 3) variant of BCR-ABL transcript: complete molecular response to imatinib.
Moravcová J; Rulcová J; Polák J; Zemanová Z; Klamová H; Haskovec C
Leuk Res; 2005 Nov; 29(11):1365-6. PubMed ID: 15876454
[No Abstract] [Full Text] [Related]
15. Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy.
Tiribelli M; Colatutto A; Marin L; Barbina G; Qualizza U; Damiani D; Toffoletti E; Medeot M; Candoni A; Tonutti E; Sala P; Fanin R
Am J Hematol; 2008 Jun; 83(6):517-8. PubMed ID: 18306359
[No Abstract] [Full Text] [Related]
16. Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation.
Caocci G; Atzeni S; Orrù N; Littera R; Culurgioni F; Marongiu F; La Nasa G
Leuk Res; 2010 Jan; 34(1):e27-9. PubMed ID: 19748671
[No Abstract] [Full Text] [Related]
17. Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia.
Chng WJ; Tan LH
Leuk Res; 2005 Jun; 29(6):719-20. PubMed ID: 15863215
[No Abstract] [Full Text] [Related]
18. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
19. Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?
Breccia M; Alimena G
Leuk Res; 2009 Nov; 33(11):1450-1. PubMed ID: 19615745
[No Abstract] [Full Text] [Related]
20. Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
Kata D; Mrówka-Kata K; Seweryn M; Pajak J; Najda J; Kyrcz-Krzemień S
Leuk Res; 2010 Sep; 34(9):e229-31. PubMed ID: 20359744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
